Scout | NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

This grant opportunity supports Phase I clinical trials for developing diagnostics and treatments for heart, lung, blood, and sleep disorders in both adults and children. It covers both trial start-up and implementation, as well as final preclinical activities necessary for trial readiness. The grant is structured in two phases; the first phase focuses on completing essential pre-trial tasks l…

Source

Agency: National Institutes of Health

Sub-agency: National Heart, Lung, and Blood Institute

Program: SBIR

Dates

Opportunity Released: April 2, 2024

Open for Submission: April 2, 2024

Submission Deadline: January 7, 2027

Application Window Closes: January 7, 2027

Keywords

heart disorders

lung disorders

blood disorders

sleep disorders

clinical trials

Phase I trials

therapeutic interventions

diagnostic interventions

preclinical activities

multisite trials

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers